Literature DB >> 8449026

Muscarinic cholinoceptors in native and cultured human corneal endothelium.

R J Walkenbach1, G S Ye, F Boney, D K Dueker.   

Abstract

Specific and high affinity binding of the potent muscarinic cholinergic antagonist, [3H]quinuclidinylbenzilate ([3H]QNB) was observed using intact native and cultured adult human corneal endothelium (HCE). Specific binding was proportional to radioligand concentration between 0.03 and 5 nM, indicating a maximal binding capacity (Bmax) of 130 fmol of [3H]QNB/mg protein and a dissociation constant (Kd) of 0.3 nM. Atropine competed effectively with [3H]QNB for binding sites; requiring 3 nM to inhibit 50% of the binding of 1 nM [3H]QNB. Carbachol also competed with [3H]QNB at higher concentrations, but nicotine did not affect [3H]QNB binding at levels up to 1 nM. [3H]QNB binding was also observed in cultured cells of adult human, rabbit, and bovine corneal endothelium. Native and cultured HCE were affinity labelled using tritium-labelled propylbenzilylcholine mustard (PBCM). Separation of the proteins in affinity labelled native and cultured tissue by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) showed that only one protein in each preparation, of 60 and 55 kilodaltons (kDa), respectively, was specifically radiolabelled. These data indicate that the corneal endothelium of human and several animal species exhibit muscarinic cholinoceptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8449026     DOI: 10.3109/02713689308999483

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  2 in total

1.  Occurrence of cholinergic nerve fibers in the human uveoscleral tissue.

Authors:  C Cavallotti; N Pescosolido; F M Leali; F Gherardi; D Cavallotti
Journal:  Int Ophthalmol       Date:  1998       Impact factor: 2.031

2.  Patients With Dry Eye Disease and Low Subbasal Nerve Density Are at High Risk for Accelerated Corneal Endothelial Cell Loss.

Authors:  Ahmad Kheirkhah; Vannarut Satitpitakul; Pedram Hamrah; Reza Dana
Journal:  Cornea       Date:  2017-02       Impact factor: 2.651

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.